Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Tyra Biosciences, Inc. (TYRA) had Return on Tangible Equity of -10.65% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-29.87M |
|
-- |
|
-- |
|
$32.94M |
|
$-32.94M |
|
$3.08M |
|
$-29.87M |
|
$-29.87M |
|
$-29.87M |
|
$-29.87M |
|
$-29.87M |
|
$-29.87M |
|
$-32.94M |
|
$-32.81M |
|
59.67M |
|
59.67M |
|
$-0.50 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$281.22M |
|
$1.35M |
|
$20.64M |
|
$301.85M |
|
$15.88M |
|
-- |
|
$5.46M |
|
$21.34M |
|
$280.51M |
|
$280.51M |
|
$280.51M |
|
53.32M |
|
| Cash Flow Statement Financials | |
$-71.52M |
|
$38.09M |
|
$3.42M |
|
$92.97M |
|
$62.95M |
|
$-30.02M |
|
$20.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-71.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.65% |
|
|
Return on Tangible Equity |
-10.65% |
-9.89% |
|
-10.65% |
|
$5.26 |
|
$-1.20 |
|
$-1.20 |
|